Trial Profile
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2024
Price :
$35
*
At a glance
- Drugs Vercirnon (Primary) ; Midazolam; Omeprazole; Pioglitazone; Rosuvastatin
- Indications Crohn's disease
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 15 Dec 2011 New trial record